Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide
about
Iron regulation of the major virulence factors in the AIDS-associated pathogen Cryptococcus neoformans.Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen.Concomitant but not causal association between surface charge and inhibition of phagocytosis by cryptococcal polysaccharide.The capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anticapsular antibodyCytotoxic T lymphocyte antigen costimulation influences T-cell activation in response to Cryptococcus neoformans.Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.Opsonization of Cryptococcus neoformans by human immunoglobulin G: role of immunoglobulin G in phagocytosis by macrophages.Opsonization of Cryptococcus neoformans by human immunoglobulin G: masking of immunoglobulin G by cryptococcal polysaccharide.Experimental cryptococcosis in normal and B-cell-deficient miceChemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neoformansFc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificityModulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans.Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytesImmune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsivenessInteraction of inflammatory cells and oral microorganisms. VII. In vitro polymorphonuclear responses to viable bacteria and to subcellular components of avirulent and virulent strains of Actinomyces viscosusPhagocytosis of Cryptococcus neoformans by normal and thioglycolate-activated macrophagesGenetic study of oxygen resistance and melanization in Cryptococcus neoformans.Meningococcal group W-135 and Y capsular polysaccharides paradoxically enhance activation of the alternative pathway of complement.Differential localization of complement component 3 within the capsular matrix of Cryptococcus neoformans.Extracellular glycoprotein from virulent and avirulent Cryptococcus species.A yeast under cover: the capsule of Cryptococcus neoformans.Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytesCapsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils.Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cellsRecombinational mapping of capsule mutations in Cryptococcus neoformansGenetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans.Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated cryptococcus neoformans.UDP glucuronate decarboxylase and synthesis of capsular polysaccharide in Cryptococcus neoformans.Immediate hypersensitivity to Cryptococcus neoformansOpsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence.Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype ABinding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants.Binding of cryptococcal polysaccharide to Cryptococcus neoformansLocalization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophilsNew fluorescence assay for the quantitation of fungi.The capsule of the fungal pathogen Cryptococcus neoformans.Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes.Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans.Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan.
P2860
Q33264398-23F35647-4D0E-4843-814D-B3E079288016Q33616470-4710C69D-EE7F-4362-AEDD-BE77822695F0Q33905575-2EFD6D78-C64E-4CD5-BE80-D0047421BD89Q34001769-53B7DFD1-49F7-43D5-A256-04500EB08F13Q34006313-7AECED17-8B25-4EA3-B8A8-461FCBB50A4AQ34009212-8343829C-0C24-45CF-83F0-0E3B76F28A24Q34088603-A7FE97E3-8ACB-4419-B5E1-A2200EC8A49DQ34088651-3C120A69-0ADB-4589-BB75-44134994E93AQ34093295-A17EA6B9-1C9F-4F5A-98C3-1F6C73E71914Q34096432-1C962492-DF9B-4C28-AEC3-DAB3C0E66610Q34123230-D0EB08F8-DE0E-4C84-929F-E8F54B7344C5Q34125581-52306B01-1498-48DF-8002-84BD3B39C446Q34182880-04951C60-C307-40D9-9235-CA8928D7A709Q34420549-A1313876-F84B-476D-ADA6-40B423C83A3CQ34453249-6062975B-7EF2-4796-8CA3-9955C61C6EDBQ34454156-EB01CCF9-D9C0-4944-980E-3E15C16B8881Q34549734-B29DAF00-21FE-4FBF-8BEE-33733D4531ABQ34624357-EB30AFCA-A307-4DE4-B989-F91D4B439AFFQ34681238-85466405-2E72-4828-AD54-7F97E9C1CB0CQ34716807-3A30A9ED-EA3E-49C2-B199-A3608821B705Q35197202-D6C58874-CB59-4C90-B924-E7B6E8488DE9Q35427625-DE851AA3-1DCE-485D-8BA3-E7CFEC7879AFQ35508763-3D17DA86-28AC-4A29-811E-AAA6A1E4248CQ35534083-7EE2DB01-8AA8-4326-B077-D554DC371927Q36294648-EEB9C15F-39E6-4B13-AFD3-7D7B13D4A7ECQ36309618-563568E6-8070-49D8-B497-A20C878BC0E3Q36346286-14E85C3B-50F8-46DE-BEF9-1FE0E413A365Q36408691-689E165A-8998-4146-AC9C-8AAE14C6462BQ36443790-4E4F05F9-265D-4775-AFBC-DC5FFBFE2F39Q36444623-9DAF6698-EECE-4D14-BD59-27D10D6FAB84Q36657718-A1E17568-B348-4A23-9B2C-3A8E41C293AEQ37006902-5E2C2DFA-7ED1-45FE-9D7E-958BF40FDC9DQ37013969-A9045D0A-642A-4191-88E8-8FF1C0A8D80FQ37097146-476D7D33-EDF9-44E3-A73E-EB4E0A418119Q37098843-93F3C962-2288-4AA9-A1E0-E72144B603DBQ37179907-27C4941C-EF29-4F78-8E37-4F49C3F12D07Q37337879-0F6ADC64-CD81-44E5-900E-FE6039E705A2Q39569976-8B69AECD-B259-4985-B0CC-00C221D2AEE8Q40373891-02D716A6-7E6D-47FC-84B3-B115125DE6A9Q40582548-C195AFCA-2A7B-49EC-BFB9-C5869FE822A8
P2860
Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide
description
1977 nî lūn-bûn
@nan
1977 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Non-encapsulated variant of Cr ...... phagocytosis by polysaccharide
@ast
Non-encapsulated variant of Cr ...... phagocytosis by polysaccharide
@en
Non-encapsulated variant of Cr ...... phagocytosis by polysaccharide
@nl
type
label
Non-encapsulated variant of Cr ...... phagocytosis by polysaccharide
@ast
Non-encapsulated variant of Cr ...... phagocytosis by polysaccharide
@en
Non-encapsulated variant of Cr ...... phagocytosis by polysaccharide
@nl
prefLabel
Non-encapsulated variant of Cr ...... phagocytosis by polysaccharide
@ast
Non-encapsulated variant of Cr ...... phagocytosis by polysaccharide
@en
Non-encapsulated variant of Cr ...... phagocytosis by polysaccharide
@nl
P2860
P1476
Non-encapsulated variant of Cr ...... phagocytosis by polysaccharide
@en
P2860
P304
P407
P577
1977-04-01T00:00:00Z